ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

Validation, Verification 2017 - Validation, Verification and Transfer of Analytical Methods from FDA/EMA, USP and ICH 2017

Date2017-10-25 - 2017-10-26

Deadline2017-10-23

VenueZurich, Switzerland, Swaziland Swaziland

KeywordsValidation; Verification and T; FDA/EMA; USP and ICH; Regulatory Affairs

Websitehttp://www.globalcompliancepanel.com/con...

Topics/Call fo Papers

Course "Validation, Verification and Transfer of Analytical Methods (Understanding and implementing guidelines from FDA/EMA, USP and ICH)" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion.
Overview:
Analytical methods and procedures should be validated to ensure reliability, consistency and accuracy of analytical data. Compendial methods should be verified to demonstrate the suitability of laboratories to successfully run the method and when methods are transferred between laboratories successful transfer should be demonstrated through testing. In case a laboratory wants to use an alternative method instead of a compendial method, equivalency of the alternative method to the compendial method should be demonstrated.
Method validation recently got highest attention from regulatory agencies and industry task forces. For example, FDA and EMA released guidelines on method validation and transfer, and USP has proposed new approaches chapters for integrated validation, verification and transfer of analytical procedures, for equivalency testing and for statistical evaluation.
This two-day workshop will give attendees the background to understand the requirements, and even more significantly, it will focus on strategies and provide tools to implement most critical requirements. It will also provide templates and examples to develop inspection ready documentation. Interactive workshop exercises will be dispersed into and between the presentations. About 50% of the total time will be dedicated to practical sessions with real life examples. After the course a variety of tools such as SOPs, validation examples and checklists will be readily available on a dedicated website that can be used to easily implement what attendees have learned in the course.
Learning Objectives:
• Learn about the regulatory background and requirements for validation of analytical methods and procedures
• Learn how to plan, execute and document development and validation of methods developed in-house
• Be able to explain the different requirements for validation, verification and transfer of analytical procedures
• Understand the principles of validating methods developed in-house, verification of compendial methods, transfer of analytical procedures and demonstrating equivalency to compendial methods
• Be able to explain your company's strategy for method validation, verification, transfer and equivalency testing
• Be able to select test parameters, test conditions and acceptance criteria for different analytical tasks
• Be able to justify and document decisions about revalidation after method changes
• Be able to define and demonstrate FDA and EU compliance to auditors and inspectors
• Be able to develop inspection ready documentation during on-going routine operation
• Understand statistical evaluation of validation test results
• Understanding what questions will be asked during audits and inspections and how to answer them
Who will benefit:
• QA Managers and Personnel
• Quality Control
• Method Development
• Analytical Chemists
• Validation Specialists
• Laboratory Managers and Supervisors
• Regulatory Affairs
• Training Departments
• Documentation Departments
• Consultants
Agenda:
Day 1 Schedule
Lectures and Workshop Exercises
Lecture 1:
Regulatory Background and Requirements
• FDA and international requirements
• The importance of ICH Q2 and USP chapters
• USP approach for method validation: New/revised Chapters 220, 1200, 1210, 1220, 1225
• Learnings from the NEW FDA and WHO method validation guidelines
• Different requirements for GLP, GCP and GMP
• The importance and steps of risk assessment
• Exercise: Define risk numbers for different methods
• Lessons from recent FDA Warning Letters
• Planning for cost-effective implementation
Lecture 2:
Going through the new FDA Method Validation guidance
• Scope and enforcement of the guidance
• Recommendations for integrated procedure lifecycle
• Expectations for quality risk assessment, Quality by Design (QbD), multivariate experiments, system suitability testing, statistics,
• Revalidation vs. periodic review
• Preparing the lab for GMP compliant validation studies
Lecture 3:
Validation of Analytical Methods and Procedures
• Developing a validation plan and SOP
• ICH Q2 validation and test parameters:
Accuracy, precision, intermediate precision, specificity, LOD, LOQ, linearity, range, robustness, ruggedness
• Examples for application specific acceptance criteria
• Examples for design and execution of test experiments
• Evaluation of test results: using statistical models
• Handling deviations from expected test results
• Going through an example validation report
Lecture 4:
Verification of Compendial Methods
• FDA and equivalent international expectations
• Scope and objectives of USP <1226>
• USP <1226> verification requirements
• Risk based approach for type and extent of verification testing
• Which validation parameters should be verified
• Logical process to set acceptance criteria
• Exercise: Application based verification testing
Day 2 Schedule
Lectures and Workshop Exercises
Lecture 1:
Transfer of Analytical Methods and Procedures
• The main objective of formal method transfer
• Learnings from EU GMP Chapter 6 on method transfer
• USP <1224> : Choosing the approach for transfer
• Approach and benefits of comparative testing:
• Developing a risk based test plan
• Planning and developing an effective transfer protocol
• Preparing the receiving lab for the transfer
• Method transfer to new technology: HPLC to UHPLC
• Preparing the method transfer report
• Exercise: Application specific comparative testing
Lecture 2:
Demonstrating Equivalency to Compendial Methods
• Method validation vs. equivalency testing
• Definition, objective and scope of alternative methods
• Justification for the use of alternative methods
• FDA and USP requirements
• Options for alternatives to approved procedures
• Exercise: Equivalency testing - what and how much
• Documentation requirements
Lecture 3:
Maintaining the Validated State
• Monitoring method performance: system suitability testing and quality control samples
• Change control procedure for analytical methods
• Handling method changes vs. adjustments
• Revalidation of analytical methods: when, what to test
• Method reviews as a cost effective alternative to time based revalidation
• Going through a review process
• Regulatory reporting of post-approval changes
• Examples for continuous improvements
Lecture 4:
Special Applications and Validation Processes
• Preview to the expected new USP general chapter <1220> "The Analytical Procedure Lifecycle"
• Method development and validation using Quality by Design principles following the new FDA Guidance
• Validation of bioanalytical methods according to the FDA and EMA guidelines
• Validation of stability indication method
Speaker
Dr. Ludwig Huber
Chief Advisor - Global FDA compliance, Labcompliance
• Chairman, presenter and panel discussion member at US-FDA Industry Training sessions and conferences
• Served as team member of PDA's task forces "21 CFR Part 11", of US-FDA internal documents, and of the GAMP® special interest group on Laboratory Systems.
• Presenter of the Year of the Institute for Validation and Technology
• Director and chief editor of www.labcompliance.com, the global on-line resource for validation and compliance issues for laboratories.
• Author of the books "Validation and Qualification in Analytical Laboratories, and "Validation of Computerized Analytical and Networked Systems"
Location: Zurich, Switzerland Date: October 25th & 26th, 2017 and Time: 9:00 AM to 6:00 PM
Venue: Mövenpick Hotel Zurich-Airport Walter Mittelholzerstrasse 8 | 8152 Glattbrugg, Zürich, Switzerland
Price:
Register now and save $200. (Early Bird)
Price: $1,695.00 (Seminar Fee for One Delegate)
Until September 10, Early Bird Price: $1,695.00 From September 11 to October 24, Regular Price: $1,895.00
Register for 5 attendees Price: $5,085.00 $8,475.00 You Save: $3,390.00 (40%)*
Register for 10 attendees Price: $9,322.00 $16,950.00 You Save: $7,628.00 (45%)*
Sponsorship Program benefits for “Quality Assurance Auditing for FDA Regulated Industry” seminar
At this seminar, world-renowned FDA Regulated Industry subject matter experts interact with CXO’s of various designations. Executives who carry vast experience about FDA Regulated Industry and Experts get down to discussing industry-related best practices, regulatory updates, changes in technologies, and much more relating to FDA Regulated Industry.
As a sponsor of these seminars, you get the opportunity to have your product and company reach out to C-Level executives in FDA Regulatory -related industries and become known among these elite executives and subject matter experts. Apart from being seen prominently at these globally held seminars, you also get talked about frequently in our correspondences with our experts and these participants.
For More Information- https://www.globalcompliancepanel.com/control/spon...
Contact us today!
NetZealous LLC DBA GlobalCompliancePanel
john.robinson-AT-globalcompliancepanel.com
support-AT-globalcompliancepanel.com
Toll free: +1-800-447-9407
Phone: +1-510-584-9661
Website: http://www.globalcompliancepanel.com
Registration Link - http://www.globalcompliancepanel.com/control/globa...
Follow us on LinkedIn: https://www.linkedin.com/company/globalcompliancep...
Like us our Facebook page: https://www.facebook.com/TrainingsAtGlobalComplian...
Follow us on Twitter: https://twitter.com/GCPanel

Last modified: 2017-08-28 15:34:51